课题基金 / 基金详情

Native PLGA nanoparticles attenuate aggregation, phosphorylation and internalization of tau protein: potential implication in the treatment of Alzheimer's disease

Native PLGA nanoparticles attenuate aggregation, phosphorylation and internalization of tau protein: potential implication in the treatment of Alzheimer's disease
天然 PLGA 纳米粒子减弱 tau 蛋白的聚集、磷酸化和内化:在阿尔茨海默病治疗中的潜在意义
批准号:
487617
负责人:
Kar Satyabrata
金额:
$72.17万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-09-01 至 2028-09-01

项目摘要

项目成果

Kar Satyabrata的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Alzheimer's disease (AD) is the most common cause of dementia affecting the elderly population in our society. People with AD suffer loss of memory and have trouble making decisions and using language. The disease is caused by two distinct clumps of prote
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biodegradable acidic nanoparticles attenuate beta-amyloid aggregation/toxicity: potential implication in the treatment of Alzheimer's disease pathology
  • 批准号:
    443438
  • 项目类别:
    Operating Grants
  • 资助金额:
    $53.22万
  • 财政年份:
    2021
  • 负责人:
    Kar Satyabrata
  • 依托单位:
Role of lysosomal enzymes cathepsins B and D in neuronal vulnerability: potential implications in Alzheimer's disease pathology
  • 批准号:
    369603
  • 项目类别:
    Operating Grants
  • 资助金额:
    $54.06万
  • 财政年份:
    2017
  • 负责人:
    Kar Satyabrata
  • 依托单位:
Role of activated astrocytes in APP metabolism and its functional implications in Alzheimer's disease pathology
  • 批准号:
    357782
  • 项目类别:
    Operating Grants
  • 资助金额:
    $49.6万
  • 财政年份:
    2016
  • 负责人:
    Kar Satyabrata
  • 依托单位:
Role of beta-amyloid peptides in kainic acid-induced toxicity and its implications in temporal lobe epilepsy
  • 批准号:
    252529
  • 项目类别:
    Operating Grants
  • 资助金额:
    $28.87万
  • 财政年份:
    2012
  • 负责人:
    Kar Satyabrata
  • 依托单位:
海外基金